InvestorsHub Logo
Followers 4
Posts 117
Boards Moderated 0
Alias Born 02/26/2017

Re: scottsmith post# 215047

Tuesday, 01/30/2018 8:33:31 PM

Tuesday, January 30, 2018 8:33:31 PM

Post# of 403159
I don't think the K trial is ending anytime soon. It's difficult to recruit and very complex in it's data collection and analysis. Besides, I don't think the main goal of a K partnership is to get a lot of up-front money on a deal. It'd be nice if it happened but I think IPIX really wants someone to pay for the long, expensive oncology trials, and to be able to tap into some BP cancer expertise for further development.

Why do you think it’s logical to wait on Prurisol results and not Kevetrin results?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News